Posts by Bagchi Law
Why Bagchi Law Supports Freedom United’s Mission to End Slavery
Bagchi Law is a proud supporter of Freedom United and we caught up with Executive Director, Joanna Ewart-James, to discuss how they are working to create a world that is resilient to trafficking and exploitation of people.
Read MoreSelecting a Strong Trademark: The Spectrum of Distinctiveness and Why It Matters
“What’s in a name? That which we call a rose by any other name would smell as sweet.” William Shakespeare, Romeo and Juliet Shakespeare suggests that a name isn’t all that important. To consumers and business owners, however, it means everything. In commerce, a name or logo can serve as a strong trademark indicating quality…
Read MoreBagchi Law Expands IP Legal Services
Attorney Mayukh Sircar to lead new Intellectual Property Law focus Bagchi Law was founded on the core belief that commercial business clients deserve the expertise of a large law firm, coupled with the care and agile nature of a boutique practice. Today Bagchi Law is announcing the launch of a new business unit that will…
Read MoreBagchi Law Welcomes New Attorneys
Bagchi Law is excited to announce our firm has added two new attorneys to the team. Tyler Demasky and Amanda Frazer-Collins recently joined our Chapel Hill law firm, and both will assist in our mission of serving our clients with the expertise of a big law firm, coupled with the care and agile nature of a boutique practice.
Read More83(b) Elections: Startup Tax Issues (Part 2)
In Part I of our Startup Tax Issues series, we discussed how to avoid penalties with valuations. But what about issues related to 83(b) elections? Startup founders or other service providers receiving restricted stock should strongly consider making an 83(b) election in the year the restricted stock is granted.
Read MoreCommon Stock Valuation: Startup Tax Issues (Part 1)
Filing taxes can be intimidating, but it’s as inevitable as death. Tax rules are complicated, subject to change, and frequently poorly written. Early-stage startup taxation is a relatively limited field and this is good news for founders. Four topics makeup about 60-80% of founder tax issues. In this two-part blog series, we will address common…
Read MoreClinical Trials in India: New Opportunities for Growth (Part 3)
In 2013, there was a slowdown in clinical trials due to clinical trial litigation. Afterward, India experienced an upward trend. Read more about the history of clinical trials and the risks in part I and part II of this series. There are several reasons behind the positive growth in clinical phase 1 and phase 2…
Read MoreClinical Trial Regulations in India (Part 2): Identifying Risks
Although India has made adjustments to match global clinical trial regulation standards, the country still has some work to do. Several grey areas still need to be addressed. In some cases, regulatory authorities are the solution. Other issues require industry practices derived from trial and error. This unfortunately raises significant risk and liability questions. Clinical…
Read MoreThe Future of ICOs: SEC Regulations & Analysis
The emergence of initial coin offerings revolutionized public companies and fundraising. With very few SEC regulations, companies were allowed to raise millions of dollars that weren’t scrutinized by red tape. Companies who were able to sell their vision and coin to the public earned big. However, ICOs are now governed by regulatory bodies that provide…
Read MoreA Guide to India Clinical Trial Regulations (Part 1): History & Overview
The Indian pharmaceutical market is worthy of attention. It’s the third-largest globally by volume and 13th largest by value. The country is also the biggest producer of generic drugs, accounting for 20% of global exports in volume. In 2017, the Drug Controller General of India announced a new clinical trials policy. This policy provided greater…
Read More